TECH

72.6700.04%
KK

Kim Kelderman

CEO, President & Director

Mr. Kim Kelderman is Director of Biorez, Inc. from 2025. Mr. Kelderman is Director of CONMED Corporation from September 8, 2025. Mr. Kelderman serves as Director of SLMP, LLC since November 2021. He served as President of the Diagnostics and Genomics Segment at Bio-Techne since he joined on April 30, 2018. He served as Chief operating Officer at Bio-Techne Corporation since November 1, 2023 until January 31, 2024 and serves as its President & Chief Executive Officer since February 01, 2024 and serves as its Director since 2023. Prior to joining Bio-Techne, he led three different businesses at Thermo Fisher Scientific including management of the Platforms and Content of the Genetic Sciences Division, where he was responsible for the Instrumentation, Software, Consumables and Assays businesses and brands such as Applied Biosystems and the legacy Affymetrix genetics portfolio. Prior to joining Thermo Fisher, Kim led the global Blood Tubes Vacutainer business as Senior Segment Leader at Becton Dickinson. He served as General Manager of GeneOhm Canada at GeneOhm Sciences, Inc. Mr. Kelderman served as Chief Operating Officer of the Oculus Innovative Sciences Inc. He joined Oculus as Executive Vice President in August of 2003. Previously, he served as President and General Manager of Jomed, Inc. a multi-site medical device company. He also has held position with Intravascular Research Ltd. Jomed GmbH, EndoSonics Europe and Medtronic Vascular. He received his Bachelor of Science degree in Mechanical Engineering from the Hogeschool Heerlen of Applied Sciences in the Netherlands.

Positions